TrialTechnology in cancer research & treatment

Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study).

Yingying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.